Table 1 Detection of GT and bmGT in sera and BALF during the course of IA.
Model of IA and day post-infection | GT | bmGT | ||
|---|---|---|---|---|
Serum | BALF | Serum | BALF | |
CGD | ||||
Day 1 | 0% | 0% | 0% | 0% |
Day 3 | 0% | 0% | 0% | 0% |
Day 5 | 0% | 0% | 0% | 0% |
Steroid-treated | ||||
Day 1 | 0% | 0% | 0% | 0% |
Day 3 | 0% | 0% | 0% | 0% |
Day 5 | 0% | 0% | 0% | 0% |
Neutropenic | ||||
Day 1 | 0% | 0% | 0% | 0% |
Day 3 | 71% 55 (14–95) | 50% 15 (8–22) | 0% | 0% |
Day 5 | 40% trace amounts at the limit of detection of the assay (~1 ng/mL) | 40% 7 (2–11) | 0% | 0% |
